XML 49 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Jan. 25, 2015
STOCK-BASED COMPENSATION  
Schedule of reconciliation of the number of options outstanding and exercisable

A reconciliation of the number of options outstanding and exercisable (in thousands) as of January 25, 2015, and changes during the quarter then ended, is as follows:

 

 

 

Shares

 

Weighted-
Average
Exercise Price

 

Weighted-
Average
Remaining
Contractual
Term

 

Aggregate
Intrinsic Value
(in thousands)

 

Outstanding at October 26, 2014

 

17,402 

 

$
24.61 

 

 

 

 

 

Granted

 

1,169 

 

52.76 

 

 

 

 

 

Exercised

 

285 

 

19.69 

 

 

 

 

 

Outstanding at January 25, 2015

 

18,286 

 

$
26.49 

 

5.4 years

 

$ 491,242

 

Exercisable at January 25, 2015

 

13,740 

 

$
21.99 

 

4.4 years

 

$ 430,900

 

 

Schedule of weighted-average grant date fair value of stock options granted, and the total intrinsic value of options exercised

The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised (in thousands) during the first quarter of fiscal years 2015 and 2014 are as follows:

 

 

 

Three Months Ended

 

 

 

January 25,
2015

 

January 26,
2014

 

Weighted-average grant date fair value

 

$   10.08

 

$

9.89 

 

 

Intrinsic value of exercised options

 

$   9,192

 

$

13,402 

 

 

 

Schedule of weighted-average assumptions used to calculate fair value of each option award

 

 

 

Three Months Ended

 

 

 

January 25,
2015

 

January 26,
2014

 

Risk-free interest rate

 

2.2 %

 

2.5%

 

Dividend yield

 

1.9 %

 

1.7%

 

Stock price volatility

 

19.0%

 

20.0%

 

Expected option life

 

8 years

 

8 years

 

 

Schedule of stock-based compensation expense, along with the related income tax benefit

 

 

 

Three Months Ended

 

(in thousands)

 

January 25,
2015

 

January 26,
2014

 

Stock-based compensation expense recognized

 

$ 5,524

 

$   4,957

 

Income tax benefit recognized

 

2,097 

 

1,884 

 

After-tax stock-based compensation expense

 

$ 3,427

 

$   3,073